Skip to main content
Stellantis N.V. logo

Stellantis N.V. — Investor Relations & Filings

Ticker · STLA ISIN · NL00150001Q9 LEI · 549300LKT9PW7ZIBDF31 XMIL Manufacturing
Open in API
Filings indexed 1,360 across all filing types
Latest filing 2020-11-23 Regulatory Filings
Country NL Netherlands
Listing XMIL STLA

About Stellantis N.V.

https://www.stellantis.com/en

Stellantis N.V. is a leading global automaker and provider of mobility solutions. The company designs, manufactures, and markets a wide range of vehicles, including passenger cars and light commercial vehicles, through a diverse portfolio of 14 automotive brands such as Jeep, Ram, Peugeot, Citroën, Opel, Fiat, and Chrysler. A key strategic focus is leading the transition to sustainable mobility through significant investment in electrification, software development, and other advanced technologies. The company is actively developing innovative solutions in autonomous driving and connected services, aiming to become a sustainable mobility technology company with a commitment to achieving carbon net zero.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings
2020-11-23 English
425 Filing
Regulatory Filings
2020-11-23 English
425 Filing
Regulatory Filings
2020-11-23 English
425 Filing
Regulatory Filings
2020-11-23 English
6-K
Regulatory Filings
2020-11-20 English
Approval of the prospectus relating to the listing of Stellantis shares
M&A Activity Classification · 95% confidence The document is an 'IMPORTANT NOTICE' dated November 20, 2020, concerning the approval of a prospectus related to the listing of Stellantis shares following the merger between Groupe PSA and Fiat Chrysler Automobiles (FCA). It explicitly mentions the filing of a registration statement on Form F-4 with the SEC and refers to the prospectus being approved by the Netherlands authority for the financial markets (AFM). The content is focused on the legal and regulatory steps surrounding a major corporate transaction (merger/listing) and the availability of the prospectus. Since the document is an announcement about the approval and availability of a key regulatory document (the prospectus) related to a significant corporate event (merger/listing), and it references SEC filings (Form F-4), it strongly aligns with documents related to corporate actions and regulatory disclosures. Given the context of a merger and the subsequent listing/prospectus approval, this is a significant corporate event disclosure. While it is an announcement, the core subject is the prospectus for the listing, which is a key part of the M&A/Financing process. However, the document itself is an announcement regarding the approval of the prospectus and directs readers to where the prospectus can be viewed, fitting the description of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the document is primarily announcing the approval of the prospectus for the listing resulting from the merger, and it is not the full prospectus or a standard financial report, 'RPA' (Report Publication Announcement) is a strong candidate if it were announcing a standard report. Given the context is a major corporate transaction (merger/listing) and the document is a formal notice about the regulatory approval of the listing prospectus, 'TAR' (M&A Activity) is relevant, but 'RPA' fits the structure of announcing the availability/approval of a key document. Since the document is a formal notice about the regulatory approval of the prospectus for the listing resulting from the merger, and it is not the full prospectus itself, it functions as an announcement of a regulatory step. Given the options, and the focus on the merger/listing, 'TAR' (M&A Activity) is the most specific category for the underlying event, but the document type is an announcement about the prospectus approval. Since the document is a formal announcement regarding the regulatory approval of the prospectus for the listing following the merger, and it is not the prospectus itself, it is best classified as a general Regulatory Filing (RNS) or related to the M&A activity (TAR). Because the core event is the merger and listing, and this is a key step announcement, TAR is highly relevant. However, the document is structured as a press release announcing the AFM's approval of the prospectus, which is a regulatory step. Given the options, and the focus on the merger/listing, TAR is the most contextually relevant high-level category for the underlying transaction, but RPA covers the announcement nature. I will lean towards TAR as the underlying event is M&A related, but since it's an announcement about a prospectus approval, RNS is a safe fallback. Given the detailed nature of the merger discussion (FCA/PSA), TAR is the best fit for the subject matter, even if it's an announcement format. Re-evaluating: The document is an 'IMPORTANT NOTICE' announcing the approval of the prospectus for the listing related to the Cross-border Merger. This is directly related to M&A activity. I will classify it as TAR.
2020-11-20 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.